All regulatory pharmacology and toxicology studies are performed in compliance with Good Laboratory Practice (GLP) regulations as presently retained by regulatory authorities.
The Quality Assurance (QA) Program and all experimental procedures are defined by current Standard Operating Procedures (SOP). The head of each QA-unit reports directly to ERBC's Group Testing Facility Manager. This procedure is fully implemented, in order to guarantee the highest level of regulatory compliance, integrity, reliability and reproducibility of experimental data.
In cooperation with our Scientific Advisory Board of internationally renowned experts and having on-line access to all major scientific databases, we are continually adapting and refining established models to reflect the most recent status of modern science. Drug research is a constantly evolving field and necessitates adoption of new and sophisticated approaches. A considerable proportion of our human and financial resources is dedicated to improvement of existing methods, and establishment and validation of new models recognized by the scientific community.
This activity has resulted in a creditable number of scientific papers and publications being regularly presented by members of our team.